Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 5Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Smoking Cessation 1Pancreatic Neoplasms 1Pain, Postoperative 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Lung Cancer Prevention 1Leiomyoma 1Inflammatory Bowel Diseases 1Duodenal Neoplasms 1Diverticulitis 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Fluorouracil 87Leucovorin 78Oxaliplatin 77Irinotecan 76Bevacizumab 50Cetuximab 42Capecitabine 42Panitumumab 17Folfox protocol 16Floxuridine 11Chemotherapy, Adjuvant 11regorafenib 10IFL protocol 10Nivolumab 9Drug Therapy 9trifluridine tipiracil drug combination 8Surgical Procedures, Operative 8Neoadjuvant Therapy 8sargramostim 7pembrolizumab 7XELOX 7Specimen Handling 7Biopsy 7Trastuzumab 6Radiotherapy 6Magnetic Resonance Spectroscopy 6HMPL-013 6tislelizumab 5encorafenib 5Trifluridine 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colonic Neoplasms × Tea × Clear all
NCT01155440 2011-11-28

Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡